Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence.

Perner F, Gyuris T, Rákóczy G, Sárváry E, Görög D, Szalay F, Kunos I, Szönyi L, Péterfy M, Takács L.

J Lab Clin Med. 1999 Jul;134(1):56-67.

PMID:
10402060
2.

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis.

Lakatos PL, Firneisz G, Borcsiczky D, Zalatnai A, Selmeci L, Szalay F.

Eur J Clin Invest. 2000 Sep;30(9):793-7.

PMID:
10998079
3.

Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.

Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH, Belyaev A, Haemers A, Scharpé S, Kupiec-Weglinski JW.

Transplantation. 1997 May 27;63(10):1495-500.

PMID:
9175816
4.

Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.

Kobayashi H, Hosono O, Mimori T, Kawasaki H, Dang NH, Tanaka H, Morimoto C.

J Rheumatol. 2002 Sep;29(9):1858-66.

PMID:
12233879
5.

Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C.

Firneisz G, Lakatos PL, Szalay F; Hungarian Viral Hepatitis Study Group..

Scand J Gastroenterol. 2001 Aug;36(8):877-80.

PMID:
11495085
6.

Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease.

Detel D, Persić M, Varljen J.

J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):65-70.

PMID:
17592366
7.
8.

Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders.

Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, Klapp BF.

Scand J Immunol. 1999 Nov;50(5):536-41.

9.

CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.

Iwaki-Egawa S, Watanabe Y, Fujimoto Y.

Cell Immunol. 1997 Jun 15;178(2):180-6.

PMID:
9225009
10.

Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).

Balzarini J, Andersson E, Schols D, Proost P, Van Damme J, Svennerholm B, Horal P, Vahlne A.

Int J Biochem Cell Biol. 2004 Sep;36(9):1848-59.

PMID:
15183349
11.

Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.

Ruiz P, Hao L, Zucker K, Zacharievich N, Viciana AL, Shenkin M, Miller J.

Transpl Immunol. 1997 Jun;5(2):152-61.

PMID:
9269038
12.

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.

van Lingen RG, van de Kerkhof PC, Seyger MM, de Jong EM, van Rens DW, Poll MK, Zeeuwen PL, van Erp PE.

Br J Dermatol. 2008 Jun;158(6):1264-72. doi: 10.1111/j.1365-2133.2008.08515.x.

PMID:
18384439
13.

The influence of age on intestinal dipeptidyl peptidase IV (DPP IV/CD26), disaccharidases, and alkaline phosphatase enzyme activity in C57BL/6 mice.

Detel D, Baticic L, Varljen J.

Exp Aging Res. 2008 Jan-Mar;34(1):49-62. doi: 10.1080/03610730701761957.

PMID:
18189167
14.

CD26/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy.

Aytac U, Dang NH.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Mar;4(1):11-8. Review.

PMID:
15032621
15.
16.

Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections.

Andrieu T, Thibault V, Malet I, Laporte J, Bauvois B, Agut H, Cahour A.

J Clin Virol. 2003 May;27(1):59-68.

PMID:
12727530
17.

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

Lambeir AM, Durinx C, Scharpé S, De Meester I.

Crit Rev Clin Lab Sci. 2003 Jun;40(3):209-94. Review.

PMID:
12892317
18.

CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry.

Klobusická M, Babusíková O.

Gen Physiol Biophys. 1999 Dec;18 Suppl 1:34-7.

PMID:
10707830
19.

Eating disorders: a role for dipeptidyl peptidase IV in nutritional control.

Hildebrandt M, Rose M, Mönnikes H, Reutter W, Keller W, Klapp BF.

Nutrition. 2001 Jun;17(6):451-4.

PMID:
11399402
20.

Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.

Proost P, Menten P, Struyf S, Schutyser E, De Meester I, Van Damme J.

Blood. 2000 Sep 1;96(5):1674-80.

Items per page

Supplemental Content

Support Center